Poseida Therapeutics Inc
(PSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 64,703 | 130,492 | 31,238 | 0 | 0 |
| Gross Profit | 64,703 | 130,492 | 31,238 | N/A | N/A |
| Operating Expenses | 194,207 | 190,438 | 172,649 | 126,549 | 85,533 |
| Operating Income | -129,504 | -59,946 | -141,411 | -126,549 | -85,533 |
| Interest Expense | 8,671 | 6,370 | 3,358 | 3,506 | 3,553 |
| Other Income | 14,852 | 2,858 | 19,795 | 280 | 2,559 |
| Pre-tax Income | -123,323 | -63,458 | -124,974 | -129,775 | -86,527 |
| Income Tax | 107 | 544 | N/A | N/A | N/A |
| Net Income Continuous | -123,430 | -64,002 | -124,974 | -129,775 | -86,527 |
| Net Income | $-123,430 | $-64,002 | $-124,974 | $-129,775 | $-86,527 |
| EPS Basic Total Ops | -1.37 | -0.89 | -2.01 | -3.61 | -6.86 |
| EPS Basic Continuous Ops | -1.37 | -0.89 | -2.01 | -3.61 | -6.86 |
| EPS Diluted Total Ops | -1.37 | -0.89 | -2.01 | -3.61 | -6.86 |
| EPS Diluted Continuous Ops | -1.37 | -0.89 | -2.01 | -3.61 | -6.86 |
| EPS Diluted Before Non-Recurring Items | -1.37 | -0.89 | -2.01 | -3.61 | -6.86 |
| EBITDA(a) | $-131,467 | $-55,705 | $-136,087 | $-123,332 | $-83,615 |